PAX8-PPARγ rearrangement in thyroid tumors

RT-PCR and immunohistochemical analyses

Marina N. Nikiforova, Paul Williams Biddinger, Christy M. Caudill, Todd G. Kroll, Yuri E. Nikiforov

Research output: Contribution to journalArticle

262 Citations (Scopus)

Abstract

A PAX8-PPARγ rearrangement has been recently identified in follicular thyroid carcinomas, but not in follicular adenomas or other thyroid tumors. We report here the analyses of PAX8-PPARγ in a series of 118 thyroid tumors using a newly developed RT-PCR assay to detect this rearrangement in frozen and paraffin-embedded tissues and using immunostaining with a PPARγ antibody. PAX8-PPARγ was detected by RT-PCR in eight of 15 (53%) follicular carcinomas and two of 25 (8%) follicular adenomas but not in 35 papillary carcinomas (including 12 follicular variants), 12 Hurthle cell carcinomas, 12 Hurthle cell adenomas, two anaplastic carcinomas, one poorly differentiated carcinoma, or 16 hyperplastic nodules. The prevalence was higher in follicular carcinomas from patients with a history of radiation exposure (three of three). Strong, diffuse nuclear immunostaining with the PPARγ antibody correlated with the presence of PAX8-PPARγ detected by RT-PCR. Most sporadic follicular carcinomas positive for PAX8-PPARγ were overtly invasive, whereas tumors lacking the rearrangement were predominantly minimally invasive. The two follicular adenomas positive for PAX8-PPARγ had trabecular growth pattern and thick capsule, but no invasion, and thus may represent "pre-invasive" follicular carcinomas. The absence of PAX8-PPARγ rearrangements in Hurthle cell tumors and papillary thyroid carcinomas highlights the differences in the molecular pathogenesis of these thyroid tumors.

Original languageEnglish (US)
Pages (from-to)1016-1023
Number of pages8
JournalAmerican Journal of Surgical Pathology
Volume26
Issue number8
DOIs
StatePublished - Jan 1 2002

Fingerprint

Peroxisome Proliferator-Activated Receptors
Thyroid Gland
Polymerase Chain Reaction
Carcinoma
Adenoma
Neoplasms
Oxyphil Cells
Follicular Adenocarcinoma
Oxyphilic Adenoma
Antibodies
Papillary Carcinoma
Paraffin
Capsules

Keywords

  • Chromosomal rearrangement
  • Follicular carcinoma
  • Immunohistochemistry
  • PAX8-PPARγ
  • Thyroid cancer

ASJC Scopus subject areas

  • Anatomy
  • Surgery
  • Pathology and Forensic Medicine

Cite this

PAX8-PPARγ rearrangement in thyroid tumors : RT-PCR and immunohistochemical analyses. / Nikiforova, Marina N.; Biddinger, Paul Williams; Caudill, Christy M.; Kroll, Todd G.; Nikiforov, Yuri E.

In: American Journal of Surgical Pathology, Vol. 26, No. 8, 01.01.2002, p. 1016-1023.

Research output: Contribution to journalArticle

Nikiforova, Marina N. ; Biddinger, Paul Williams ; Caudill, Christy M. ; Kroll, Todd G. ; Nikiforov, Yuri E. / PAX8-PPARγ rearrangement in thyroid tumors : RT-PCR and immunohistochemical analyses. In: American Journal of Surgical Pathology. 2002 ; Vol. 26, No. 8. pp. 1016-1023.
@article{8e85e2155a3c4e239959a2ca7d878209,
title = "PAX8-PPARγ rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses",
abstract = "A PAX8-PPARγ rearrangement has been recently identified in follicular thyroid carcinomas, but not in follicular adenomas or other thyroid tumors. We report here the analyses of PAX8-PPARγ in a series of 118 thyroid tumors using a newly developed RT-PCR assay to detect this rearrangement in frozen and paraffin-embedded tissues and using immunostaining with a PPARγ antibody. PAX8-PPARγ was detected by RT-PCR in eight of 15 (53{\%}) follicular carcinomas and two of 25 (8{\%}) follicular adenomas but not in 35 papillary carcinomas (including 12 follicular variants), 12 Hurthle cell carcinomas, 12 Hurthle cell adenomas, two anaplastic carcinomas, one poorly differentiated carcinoma, or 16 hyperplastic nodules. The prevalence was higher in follicular carcinomas from patients with a history of radiation exposure (three of three). Strong, diffuse nuclear immunostaining with the PPARγ antibody correlated with the presence of PAX8-PPARγ detected by RT-PCR. Most sporadic follicular carcinomas positive for PAX8-PPARγ were overtly invasive, whereas tumors lacking the rearrangement were predominantly minimally invasive. The two follicular adenomas positive for PAX8-PPARγ had trabecular growth pattern and thick capsule, but no invasion, and thus may represent {"}pre-invasive{"} follicular carcinomas. The absence of PAX8-PPARγ rearrangements in Hurthle cell tumors and papillary thyroid carcinomas highlights the differences in the molecular pathogenesis of these thyroid tumors.",
keywords = "Chromosomal rearrangement, Follicular carcinoma, Immunohistochemistry, PAX8-PPARγ, Thyroid cancer",
author = "Nikiforova, {Marina N.} and Biddinger, {Paul Williams} and Caudill, {Christy M.} and Kroll, {Todd G.} and Nikiforov, {Yuri E.}",
year = "2002",
month = "1",
day = "1",
doi = "10.1097/00000478-200208000-00006",
language = "English (US)",
volume = "26",
pages = "1016--1023",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - PAX8-PPARγ rearrangement in thyroid tumors

T2 - RT-PCR and immunohistochemical analyses

AU - Nikiforova, Marina N.

AU - Biddinger, Paul Williams

AU - Caudill, Christy M.

AU - Kroll, Todd G.

AU - Nikiforov, Yuri E.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - A PAX8-PPARγ rearrangement has been recently identified in follicular thyroid carcinomas, but not in follicular adenomas or other thyroid tumors. We report here the analyses of PAX8-PPARγ in a series of 118 thyroid tumors using a newly developed RT-PCR assay to detect this rearrangement in frozen and paraffin-embedded tissues and using immunostaining with a PPARγ antibody. PAX8-PPARγ was detected by RT-PCR in eight of 15 (53%) follicular carcinomas and two of 25 (8%) follicular adenomas but not in 35 papillary carcinomas (including 12 follicular variants), 12 Hurthle cell carcinomas, 12 Hurthle cell adenomas, two anaplastic carcinomas, one poorly differentiated carcinoma, or 16 hyperplastic nodules. The prevalence was higher in follicular carcinomas from patients with a history of radiation exposure (three of three). Strong, diffuse nuclear immunostaining with the PPARγ antibody correlated with the presence of PAX8-PPARγ detected by RT-PCR. Most sporadic follicular carcinomas positive for PAX8-PPARγ were overtly invasive, whereas tumors lacking the rearrangement were predominantly minimally invasive. The two follicular adenomas positive for PAX8-PPARγ had trabecular growth pattern and thick capsule, but no invasion, and thus may represent "pre-invasive" follicular carcinomas. The absence of PAX8-PPARγ rearrangements in Hurthle cell tumors and papillary thyroid carcinomas highlights the differences in the molecular pathogenesis of these thyroid tumors.

AB - A PAX8-PPARγ rearrangement has been recently identified in follicular thyroid carcinomas, but not in follicular adenomas or other thyroid tumors. We report here the analyses of PAX8-PPARγ in a series of 118 thyroid tumors using a newly developed RT-PCR assay to detect this rearrangement in frozen and paraffin-embedded tissues and using immunostaining with a PPARγ antibody. PAX8-PPARγ was detected by RT-PCR in eight of 15 (53%) follicular carcinomas and two of 25 (8%) follicular adenomas but not in 35 papillary carcinomas (including 12 follicular variants), 12 Hurthle cell carcinomas, 12 Hurthle cell adenomas, two anaplastic carcinomas, one poorly differentiated carcinoma, or 16 hyperplastic nodules. The prevalence was higher in follicular carcinomas from patients with a history of radiation exposure (three of three). Strong, diffuse nuclear immunostaining with the PPARγ antibody correlated with the presence of PAX8-PPARγ detected by RT-PCR. Most sporadic follicular carcinomas positive for PAX8-PPARγ were overtly invasive, whereas tumors lacking the rearrangement were predominantly minimally invasive. The two follicular adenomas positive for PAX8-PPARγ had trabecular growth pattern and thick capsule, but no invasion, and thus may represent "pre-invasive" follicular carcinomas. The absence of PAX8-PPARγ rearrangements in Hurthle cell tumors and papillary thyroid carcinomas highlights the differences in the molecular pathogenesis of these thyroid tumors.

KW - Chromosomal rearrangement

KW - Follicular carcinoma

KW - Immunohistochemistry

KW - PAX8-PPARγ

KW - Thyroid cancer

UR - http://www.scopus.com/inward/record.url?scp=0035984201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035984201&partnerID=8YFLogxK

U2 - 10.1097/00000478-200208000-00006

DO - 10.1097/00000478-200208000-00006

M3 - Article

VL - 26

SP - 1016

EP - 1023

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 8

ER -